The inhibitory effects of β-amyloid on glutamate and glucose uptakes by cultured astrocytes

Brain Research

Volumn 754, Issue 1-2, 1997, Pages 65-71

  Parpura Gill, Aleksandra ^a   Beitz, Donald ^a   Uemura, Etsuro ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

amyloid; Alzheimer's disease; astrocyte; glucose uptake; glutamate uptake

Indexed keywords

AMYLOID BETA PROTEIN; GLUTAMIC ACID;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; GLUCOSE TRANSPORT; NEUROTRANSMITTER UPTAKE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BIOLOGICAL TRANSPORT; CELLS, CULTURED; GLUCOSE; GLUTAMIC ACID; HIPPOCAMPUS; PEPTIDE FRAGMENTS; PHLORETIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030894036     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00043-7     Document Type: Article

References (54)

1. Araujo, D.M. and Cotman, C.W., β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease, Brain Res., 569 (1992) 141-145.
2. Beckman, J., Beckman, T., Chen, J., Marshall, P. and Greenman, B., Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide, Proc. Natl. Acad. Sci. USA, 87 (1990) 1620-1624.
3. Cafe, C., Torri, C., Bertorelli, L., Angeretti, N., Lucca, E., Forloni, G. and Marzatico, F., Oxidative stress after acute and chronic application of β-amyloid fragment 25-35 in cortical cultures, Neurosci. Lett., 203 (1996) 61-65.
4. Chao, C.C., Hu, S., Molitor, T.W., Shaskan, E.G. and Peterson, P.K., Activated microglia mediate neuronal cell injury via a nitric oxide mechanism, J. Immunol., 149 (1992) 2736-2741.
5. Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system, Neuron, 1 (1988) 623-634.
6. Dawson, V.L., Dawson, T.M., London, E.D., Bredt, D.S. and Snyder, S.H., Nitric oxide mediates glutamate neurotoxicity in primary cortical culture, Proc. Natl. Acad. Sci. USA, 88 (1991) 6368-6371.
7. Duara, R., Grady, C., Haxby, J., Sundaram, M., Cutler, N.R., Heston, L., Moore, A., Schlageter, N., Larson, S. and Rapoport, S.I., Positron emission tomography in Alzheimer's disease, Neurology, 36 (1986) 879-887.
8. Farinelli, S.E. and Nicklas, W.J., Glutamate metabolism in rat cortical astrocyte cultures, J. Neurochem., 58 (1992) 1905-1915.
9. Flott, B. and Seifert, W., Characterization of glutamate uptake systems in astrocyte primary cultures from rat brain, Glia, 4 (1991) 293-304.
10. Forloni, G., Chiesa, R., Smiroldo, S., Verga, L., Salmona, M., Tagliavini, F. and Angeretti, N., Apoptosis mediated neurotoxicity induced by chronic application of β-amyloid fragment 25-35, NeuroReport, 4 (1993) 523-526.
11. Frautschy, S.A., Baired, A. and Cole, G.M., Effects of injected Alzheimer β-amyloid cores in rat brain, Proc. Natl. Acad. Sci. USA, 88 (1991) 8362-8366.
12. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagopian, S., Johnson-Wood, K., Khan, K., Lee, M., Lebowitz, P., Lieberburg, I., Little, S., Masliah, E., McClongue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B. and Zhao, J., Alzheimer-type neuropathy in transgenic mice overexpressing V717F β-amyloid precursor protein, Nature, 373 (1995) 523-527.
13. Gomez-Pinilla, F., Cummings, G.J. and Cotman, C.W., Induction of basic fibroblast growth factor in Alzheimer's disease pathology, NeuroReport, 1 (1990) 211-214.
14. Goodwin, J.L., Uemura, E. and Cunnick, J.E., Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ, Brain Res., 692 (1995) 207-214.
15. Griffin, W.S.T., Stanley, L.C., Ling, C., White, L., MacLeod, V., Perrot, L.J., White, C.L. and Araoz, C., Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease, Proc. Natl. Acad. Sci. USA, 86 (1989) 7611-7615.
16. Haga, S., Akai, K. and Ishii, T., Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain, Acta Neuropathol., 11 (1989) 569-575.
17. Hara, M., Matsuda, Y., Hirai, K., Okumura, N. and Nakagawa, H., Characteristics of glucose transport in neuronal cells and astrocytes from rat brain in primary culture, J. Neurochem., 52 (1989) 902-908.
18. Hardy, J. and Allsop, D., Amyloid deposition as central event in the etiology of Alzheimer's disease, Trends Neurosci., 12 (1991) 383-388.
19. Harr, S.D., Simonian, N.A. and Hyman, B.T., Functional alterations in Alzheimer's disease: Decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone, J. Neuropathol. Exp. Neurol., 54 (1995) 38-41.
20. Harris, M.E., Carney, J.M., Cole, P.S., Hensley, K., Howard, B.J., Martin, L., Bummer, P., Wang, Y., Pedigo, N.W., Jr. and Butterfield, D. A., β-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in clutured astrocytes: implications for Alzheimer's disease, NeuroReport, 6 (1995) 1875-1879.
21. +-dependent glutamate uptake in rat hippocampal astrocyte cultures, J. Neurochem., 67 (1996) 277-286.
22. Hensley, K., Carney, J.M., Mattson, M.P., Aksenova, M., Harris, M., Wu, J.F., Floyd, R.A. and Butterfield, D.A., A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease, Proc. Natl. Acad. Sci. USA, 91 (1994) 3270-3274.
23. Hoyer, S., Abnormalities of glucose metabolism in Alzheimer's disease, Ann. NY Acad. Sci., 640 (1991) 53-64.
24. Ikeda, S., Yanagisawa, N., Allsop, D. and Glenner, G.G., Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy, Human Pathol., 21 (1990) 1221-1226.
25. Jagus, W.J., Seab, J.P., Huesman, R.H., Valk, P.E., Mathis, C.A., Reed, B.R., Coxson, P.G. and Budinger, T.F., Diminished glucose transport in Alzheimer's disease: dynamic PET studies, J. Cereb. Blood Flow Metab., 11 (1991) 323-330.
26. Joseph, R. and Han, E., Amyloid β-protein fragment 25-35 causes activation of cytoplasmic calcium in neurons, Biochem. Biophys. Res. Commun., 184 (1992) 1441-1447.
27. Kanai, Y., Smith, C.P. and Hediger, A., The elusive transporters with a high affinity for glutamate uptake, Trends Neurosci., 16 (1993) 365-370.
28. Koh, J.Y., Yang, L.L. and Cotman, C.W., β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage, Brain Res., 533 (1990) 315-320.
29. Marcus, D.L., de Leon, M.J., Goldman, J., Logan, J., Christman, D.R., Wolf, A.P., Fowler, J.S., Hunter, K., Tsai, J., Pearson, J. and Freedman, M.L., Altered glucose metabolism in microvessels from patients with Alzheimer's disease, Ann. Neurol., 26 (1989) 91-94.
30. Marotta, C.A., Majocha, R.E. and Tate, B., Molecular and cellular biology of Alzheimer amyloid, J. Mol. Neurosci., 3 (1992) 111-125.
31. Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I. and Rydel, R.E., β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci., 12 (1992) 376-389.
32. Meldrum, B. and Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease, Trrends Pharmacol. Sci., 11 (1990) 379-387.
33. 3H]glutamate in rat brain tissue, Brain Res., 115 (1976) 139-144.
34. Nichols, D. and Attwell, D., The release and uptake of excitatory amino acids, Trends Pharmacol. Sci., 11 (1990) 462-468.
35. Norenberg, M.D. and Martinez-Hernandez, A., Fine structural localization of glutamine sythetase in astrocytes of rat brain, Brain. Res., 161 (1979) 303-310.
36. Ogata, T., Nakamura, Y., Shibata, T. and Kataoka, K., Release of excitatory amino acids from hippocampal astrocytes induced by a hypoxic-hypoglycemic stimulation, J. Neurochem., 58 (1992) 1957-1959.
37. Parpura-Gill, A., Martens, C. and Uemura, E., β-Amyloid inhibits glutamate uptake in cultured rat astrocytes, Soc. Neurosci. Abstr., (1995) 194.3.
38. Pellerin, L. and Magistretti, P.J., Glutamate uptake into astrocytes stimulates aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization, Proc. Natl. Acad. Sci. USA, 91 (1994) 10625-10629.
39. Piani, D., Frei, K., Pfister, H.W. and Fontana, A., Glutamate uptake by astrocytes is inhibited by reactive oxygen intermediates but not by other macrophage-derived molecules including cytokines, leukotrienes or platelet-activating factor, J. Neuroimmunol., 48 (1993) 99-104.
40. Pike, C.J., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W., In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity, Brain Res., 563 (1991) 311-314.
41. Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W., Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state, J. Neurosci., 13 (1993) 1876-1887.
42. 3H-glutamate transport in synaptosomes, Synapse, 18 (1994) 21-26.
43. Rapoport, S.I., Horwitz, B., Grady, C.L., Haxby, J.V., DeCarli, C. and Schapiro, M.B., Abnormal brain glucose metabolism in Alzheimer's disease, as measured by positron emission tomography. In Fuel Homeostasis and the Nervous System, Plenum Press, New York, 1991, pp. 231-248.
44. Riege, W.H. and Metter, E.J., Cognitive and brain imaging measures of Alzheimer's disease, Neurobiol. Aging, 9 (1988) 41-42.
45. Rosenberg, P.A. and Aizenman, E., Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex, Neurosci. Lett., 103 (1989) 162-168.
46. Rosenberg, P.A., Amin, S. and Leitner, M., Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture, J. Neurosci., 12 (1992) 56-61.
47. Siesjo, B.K., Calcium and cell death, Magnesium, 8 (1989) 223-237.
48. Simpson, I.A., Koteswara, K.R., Davies-Hill, T., Horner, W.G. and Davies, P., Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease, Ann. Neurol., 35 (1994) 546-551.
49. Southam, E. and Garthwait, J., Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices, Neurosci. Lett., 130 (1991) 107-111.
50. Swanson, R.A., Astrocyte glutamate uptake during chemical hypoxia in vitro, Neurosci. Lett., 147 (1992) 143-146.
51. Swanson, R.A., Chen, J. and Graham, S.H., Glucose can fuel glutamate uptake in ischemic brain, J. Cereb. Blood Flow Metab., 14 (1994) 1-6.
52. Swanson, R.A., Yu, A.C.H., Chan, P.H. and Sharp, F.R., Glutamate increases glycogen content and reduces glucose utilization in primary astrocyte culture, J. Neurochem., 54 (1990) 490-496.
53. G-nitro-L-arginine of L-glutamate-induced neurotoxicity in cultured neonatal rat cortical neurons. Prolonged application enhances neuroprotective efficacy, Neuroscience, 55 (1993) 893-901.
54. Yankner, B., Dawes, L., Fisher, S., Villa-Komaroff, L., OsterGranite, M. and Nerve, R., Neurotoxicity of a fragment of the amyloid precuror associated with Alzheimer's disease, Science, 245 (1989) 417-420.